A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

NCT07005752 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

484

Enrollment

INDUSTRY

Sponsor class

Conditions

Cholesterol Cholelithiasis

Interventions

DRUG: CnU cap. 250mg & Ursa placebo tab. 200mg
DRUG: Ursa tab. 200mg & CnU placebo cap. 250mg

Sponsor

Myungmoon Pharma. Co. Ltd.